Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Early Phase 1
1(25.0%)
Phase 1
1(25.0%)
4Total
N/A(2)
Early Phase 1(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07314411Not ApplicableRecruiting

Carotenoid Supplementation and Retinal Health in Healthy Adults

Role: collaborator

NCT06965426Not ApplicableRecruiting

Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study

Role: collaborator

NCT06270680Early Phase 1Completed

Carotenoids for Collision Athletes

Role: collaborator

NCT03959592Phase 1Terminated

Macular Pigment and Visual Performance in Glaucoma Patients

Role: collaborator

All 4 trials loaded